The importance of testing PET-directed therapy in patients with Hodgkin Lymphoma

James O. Armitage

doi:10.1007/s11899-011-0092-z

The importance of testing PET-directed therapy in patients with Hodgkin Lymphoma

James O. Armitage

Research output: Contribution to journal › Review article › peer-review

2 Scopus citations

Abstract

Measuring the rapidity of response by PET scan and changing the treatment regimen in slow responders may lead to an improved outcome. Ongoing studies addressing this possibility have the potential to answer this question and need to be supported.

Original language	English (US)
Pages (from-to)	155-156
Number of pages	2
Journal	Current Hematologic Malignancy Reports
Volume	6
Issue number	3
DOIs	https://doi.org/10.1007/s11899-011-0092-z
State	Published - Sep 2011

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1007/s11899-011-0092-z

Cite this

@article{53518c07b0a444c9a97a33c410894d36,

title = "The importance of testing PET-directed therapy in patients with Hodgkin Lymphoma",

abstract = "Measuring the rapidity of response by PET scan and changing the treatment regimen in slow responders may lead to an improved outcome. Ongoing studies addressing this possibility have the potential to answer this question and need to be supported.",

author = "Armitage, {James O.}",

year = "2011",

month = sep,

doi = "10.1007/s11899-011-0092-z",

language = "English (US)",

volume = "6",

pages = "155--156",

journal = "Current Hematologic Malignancy Reports",

issn = "1558-8211",

publisher = "Springer Science + Business Media",

number = "3",

}

TY - JOUR

T1 - The importance of testing PET-directed therapy in patients with Hodgkin Lymphoma

AU - Armitage, James O.

PY - 2011/9

Y1 - 2011/9

N2 - Measuring the rapidity of response by PET scan and changing the treatment regimen in slow responders may lead to an improved outcome. Ongoing studies addressing this possibility have the potential to answer this question and need to be supported.

AB - Measuring the rapidity of response by PET scan and changing the treatment regimen in slow responders may lead to an improved outcome. Ongoing studies addressing this possibility have the potential to answer this question and need to be supported.

UR - http://www.scopus.com/inward/record.url?scp=80055061887&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80055061887&partnerID=8YFLogxK

U2 - 10.1007/s11899-011-0092-z

DO - 10.1007/s11899-011-0092-z

M3 - Review article

C2 - 21670982

AN - SCOPUS:80055061887

SN - 1558-8211

VL - 6

SP - 155

EP - 156

JO - Current Hematologic Malignancy Reports

JF - Current Hematologic Malignancy Reports

IS - 3

ER -

The importance of testing PET-directed therapy in patients with Hodgkin Lymphoma

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this